Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Morris

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Diabetologia|October 15, 2008
Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetesS Rafiq, D Melzer, M N Weedon, et al.
Diabetologia|August 16, 2012
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in ScotlandC A Jackson, N R V Jones, J J Walker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort studyA J Swerdlow, S P Laing, I Dos Santos Silva, et al.
Diabetologia|June 13, 2012
Diabetic retinopathy at diagnosis of type 2 diabetes in ScotlandH C Looker, S O Nyangoma, D Cromie, et al.
The British Journal of Ophthalmology|March 7, 2014
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening ProgrammeH C Looker, S O Nyangoma, D T Cromie, et al.
Diabetologia|September 5, 2012
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsH M Colhoun, S J Livingstone, H C Looker, et al.
Diabetologia|November 9, 2013
Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter]H C Looker, S O Nyangoma, D T Cromie, et al.
Diabetologia|May 22, 2013
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programmeH C Looker, S O Nyangoma, D T Cromie, et al.
Diabetologia|September 30, 2010
A role for coding functional variants in HNF4A in type 2 diabetes susceptibilityB Jafar-Mohammadi, C J Groves, A P Gjesing, et al.
Clinical Pharmacology and Therapeutics|October 2, 2013
Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular eventsM Leusink, N C Onland-Moret, F W Asselbergs, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Diabetologia|October 15, 2008
Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetesS Rafiq, D Melzer, M N Weedon, et al.
Diabetologia|August 16, 2012
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in ScotlandC A Jackson, N R V Jones, J J Walker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort studyA J Swerdlow, S P Laing, I Dos Santos Silva, et al.
Diabetologia|June 13, 2012
Diabetic retinopathy at diagnosis of type 2 diabetes in ScotlandH C Looker, S O Nyangoma, D Cromie, et al.
The British Journal of Ophthalmology|March 7, 2014
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening ProgrammeH C Looker, S O Nyangoma, D T Cromie, et al.
Diabetologia|September 5, 2012
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsH M Colhoun, S J Livingstone, H C Looker, et al.
Diabetologia|November 9, 2013
Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter]H C Looker, S O Nyangoma, D T Cromie, et al.
Diabetologia|May 22, 2013
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programmeH C Looker, S O Nyangoma, D T Cromie, et al.
Diabetologia|September 30, 2010
A role for coding functional variants in HNF4A in type 2 diabetes susceptibilityB Jafar-Mohammadi, C J Groves, A P Gjesing, et al.
Clinical Pharmacology and Therapeutics|October 2, 2013
Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular eventsM Leusink, N C Onland-Moret, F W Asselbergs, et al.
Pageof 18